Testicular Cancer Rates Among Hispanic Men Have Been Rising for 30 Years

April is Testicular Cancer Awareness Month. And this year, one study in particular deserves more attention than it has gotten.

For a long time, testicular cancer was described — in medical literature, in awareness campaigns, in locker room conversations — as something that primarily affected young White men. That framing was always incomplete. And a new 30-year study makes that even harder to ignore.

Research published in the journal Cancer and supported by the NCI's Division of Cancer Epidemiology and Genetics analyzed SEER data from 1992 to 2021. The finding: testicular germ cell tumor (TGCT) incidence among Hispanic men in the U.S. has been rising at an average annual rate of 3.03% — and rates now match, and in some analyses surpass, those of non-Hispanic White men.

That is not a small shift. That is three decades of data pointing in one direction.

Being Diagnosed Younger, at a Later Stage

The numbers that should stop you are not just about incidence. They are about what happens when a diagnosis comes.

Hispanic men with TGCT tend to be diagnosed at a median age of 29, compared to 35 for non-Hispanic White men. Younger, yes — but also more likely to be diagnosed at an advanced stage.

Those two facts together tell a story. It is not that testicular cancer is more aggressive in Hispanic men by nature. It is that something is happening between when a symptom first appears and when someone finally gets a diagnosis. That gap has a cost.

There are real reasons that gap exists. Language barriers in healthcare settings. Less access to primary care. Cultural norms around masculinity that make it harder to talk about a lump, a heaviness, a change that feels embarrassing to name. The quiet calculation that maybe it will go away on its own, or that bringing it up will create more problems than it solves.

None of that is a failure of the individual. It is a failure of systems that were not built with you in mind.

What This Means If You Are a Hispanic or Latino Man

Testicular cancer is one of the most treatable cancers when it is caught early. Stage I survival rates are exceptionally high. Stage III is still very treatable — but the road is longer, harder, and more disruptive to your life, your work, your family.

Knowing your body matters. A monthly self-exam takes about two minutes. A lump, swelling, a dull ache in the lower abdomen, a feeling of heaviness in the scrotum — these are worth a conversation with a doctor. Not eventually. Soon.

If you do not have a regular doctor, community health centers offer low-cost or sliding-scale care. You deserve to be seen by someone who takes your concern seriously.

April is Testicular Cancer Awareness Month. This study is the signal. The question is whether the healthcare system, and the awareness conversation around testicular cancer, will actually change to meet the reality it is describing. If there is a month to start that conversation, this is it.

You should not have to fight harder for an early diagnosis just because of who you are.